2xN — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

BioAge Labsbioagelabs.com in 𝕏NASDAQ: BIOAFeb 2024

BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.

BiotechHealthtechLongevityRichmond, US

Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Founder)inEric Morgen(Founder)inDov Goldstein(Executive Officer)in

BoardPatrick Enright(Director)in

Co-investorsAndreessen Horowitz Elad Gil Felicis Ventures Green Sands Equity IA Seed Ventures Longitude Capital +18 more

Kvantifykvantify.com inSeed · Jul 2024

Kvantify develops software that runs on both quantum computers and classical computing architectures (CPU/GPU) to solve chemistry and biology problems for molecular and drug discovery.

BiotechDeep TechQuantum ComputingKøbenhavn Ø, DK

Co-investorsQAI Ventures Redstone Tane Fund Balderton Capital BioCapital Delphinus Venture Capital +3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.